Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Neurocrine Biosciences In...

    NASDAQ: NBIX · Real-Time Price · USD
    133.08
    1.77 (1.35%)
    At close: Aug 15, 2025, 1:28 PM

    Neurocrine Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 2.36B 1.89B 1.49B 1.13B
    Cost of Revenue
    		 34M 39.7M 23.2M 14.3M
    Gross Profit
    		 2.32B 1.85B 1.47B 1.12B
    Operating Income
    		 570.5M 250.9M 249M 196.9M
    Interest Income
    		 91M n/a 11.2M n/a
    Pretax Income
    		 486M 332.1M 213.9M 101.4M
    Net Income
    		 341.3M 249.7M 154.5M 89.6M
    Selling & General & Admin
    		 1.01B 887.6M 752.7M 583.3M
    Research & Development
    		 731.1M 565M 463.8M 328.1M
    Other Expenses
    		 12.5M 143.9M n/a n/a
    Operating Expenses
    		 1.75B 1.6B 1.22B 911.4M
    Interest Expense
    		 126.6M 4.6M 7.1M 25.8M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 1.78B 1.64B 1.24B 925.7M
    Income Tax Expense
    		 144.7M 82.4M 59.4M 11.8M
    Shares Outstanding (Basic)
    		 100.4M 97.7M 95.8M 94.6M
    Shares Outstanding (Diluted)
    		 103.7M 101M 98.9M 97.9M
    EPS (Basic)
    		 3.40 2.56 1.61 0.95
    EPS (Diluted)
    		 3.29 2.47 1.56 0.92
    EBITDA
    		 639.7M 358M 264.6M 218.7M
    EBIT
    		 612.6M 336.7M 249M 207.8M
    Depreciation & Amortization
    		 27.1M 21.3M 15.6M 10.9M

    Add to Watchlist